ArticleExperimental and therapeutic medicine2026
No increased risk of hepatic enzyme abnormalities with non-peptidic thrombopoietin receptor agonists in immune thrombocytopenia: A meta-analysis of randomized controlled trials.
Nan Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.